| Summary: | 碩士 === 高雄醫學大學 === 醫務管理暨醫療資訊學系碩士班 === 104 === Objective: The study purposed to evaluate the trends of adherence in inhaled drugs for chronic obstructive pulmonary disease (COPD) patients and to explore the associated factors of influence and understanding of drug inhaled medication compliance, whether incorporated sound development of the disease affects the distribution and consumption of medical resources utilization.
Methods: This study is a retrospective observational study, and research materials from the NHI one million people return profile data from 2004 to 2008. The subjects in the target date for the first file in the diagnosis of chronic obstructive pulmonary disease (COPD) which ICD-9 diagnosis code of 496 patients. Defined as having diagnosed between 2004 to 2008 year ,January to December period and contains the patient''s inhaled drug disposition codes to use inhaled medicines in terms of the number of days to hold the rate of the drug (medication possession ratio, MPR), with chronic obstructive pulmonary disease (COPD) Discussion related to the medication compliance impact factor.
Results: According to the 2004-2012 National Health Insurance one million people return profile data for analysis, t test MPR through the chi-square test and independent samples for urban and rural properties, socioeconomic status, hospital ownership do, CCI index and age there is a significant difference. After the diagnosis of male patients over the age of 65 the number of outpatient visits than women and also increase the cost of the second year, inhaled medication adherence clinic the higher frequency significantly, the relative property will affect patients’ medication compliance. In the four years after the onset of the drug inhaled medication compliance by its high survival rate higher, but in the four years before the onset of drug inhaled medication compliance by its high survival rate is low.
Conclusions and Recommendations: GOLD consensus currently on treatment, inhaled drugs not only can relieve the symptoms of these patients, but also can improve medical outcomes. On clinical recommendations should strength its integration with chronic obstructive pulmonary disease according to care and collect data of lung function and mMRC and CAT questionnaire for assessment of symptoms, so that patients get better medical treatment.
|
|---|
